Ranibizumab

What is Ranibizumab?

Ranibizumab (trade name Lucentis) is a monoclonal antibody fragment (Fab) derived from the same parent mouse antibody as bevacizumab (Avastin). It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.

Questions and answers on "Ranibizumab"

Hi .... I am a man 65 years old and am suffering of Wet Degenerative Macula ... my problem started a year ago ... I have taken 6 injections of...

doctor1 MD

Lucentis and Avastin are 2 intravitreal treatment options that have gained a lot of popularity recently in ophthalmology due to their anti VEGF...

Read Full Thread   Ask a Doctor Now

Team,

My Father in law (71 Yrs) has been diagnosed with AMD and has taken 3 (R2, L1) injections of Lucentis so far. He has been asked to take 3...

doctor1 MD

Brief Answer:
I advice you to continue with lucentis.

Detailed Answer:
Hello
Welcome to Health care magic

I am Dr. DADAPEER K, an Ophthalmologist...

Read Full Thread   Ask a Doctor Now

Please guide - retina problem

doctor1 MD

Brief Answer:
Degenerative myopia.

Detailed Answer:
Hi,
Thanks for posting query on this forum,

The macula is the part of the retina responsible...

Read Full Thread   Ask a Doctor Now

Recent questions on Ranibizumab


Ask Question
Doctor Image
MD

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Drugs/Medications
Related Treatment/Therapy
Related Lab Tests